Accordingly, Mcl-1-protein turn-over was examined in DLBCL cells in the absence or presence of BDA-366, whereby protein synthesis was inhibited using cycloheximide (CHX, 20 μg/ml) in the HT cells. Here, MCL1 is linked to diffuse large B-cell lymphoma.